Milestone Scientific Inc. (MLSS) Q2 2026 Earnings Call Transcript
Milestone Scientific Inc. (MLSS) Q1 2026 Earnings Call Transcript
Milestone Scientific Inc. (MLSS) Q4 2025 Earnings Call Transcript
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| BZ Brandon Zatopek Commonwealth Equity Services LLC | 44,782 | $14,380 | $21,495.36 | $7,115.36 | 49.48% |
Richard Slavik Newbridge Financial Services Group Inc. | 141,000 | $44,202 | $70,500 | $26,298 | 59.5% |
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Eric C. Hines CEO | AMEX Exchange | 59935P209 CUSIP |
| US Country | 15 Employees | - Last Dividend | 14 Jan 2004 Last Split | 3 Nov 1995 IPO Date |
Milestone Scientific Inc. is a pioneering biomedical technology research and development company focused on inventing, developing, and commercializing patented injection technologies and devices for medical, dental, and cosmetic applications. Operating globally, with a significant presence in the United States, China, and other international markets, the company is structured into two primary segments: Dental and Medical. Since its inception in 1989, Milestone Scientific Inc. has been deeply committed to enhancing the delivery of healthcare by making injections less painful and more efficient, encapsulating its mission in their innovative suite of products. The company is based in Roseland, New Jersey, where it continues to push the envelope in technological advancements within its field.
Milestone Scientific Inc. offers a wide range of cutting-edge products aimed at improving the delivery of anesthetic and therapeutic drugs. Below is a detailed overview of their key offerings: